Chronic Hepatitis C Virus Infection in Hemodialysis Patients: Treatment Outcomes and Drug-drug Interactions Management
Journal Title: Çocuk Acil ve Çocuk Yoğun Bakım Dergisi - Year 2019, Vol 72, Issue 1
Abstract
Objectives: The aim of this study was to evaluate the success of the paritaprevir/ritonavir/ombitasvir/dasabuvir (PROD), ledipasvir/sofosbuvir (LDV/ SOF) and peginterferon (Peg-IFN) alfa-2a in the elimination of chronic hepatitis C virus (HCV) infection in HCV positive hemodialysis patients, and to assess the management of concomitant drug-drug interactions in patients receiving direct acting antiviral (DAA). Materials and Methods: The demographical characteristics, comorbid diseases, laboratory data, and treatment regimen and duration of 10 patients who were infected with HCV genotype 1 were retrospectively screened from the electronic hospital records. The patients were divided into 3 groups according to treatment regimen: PROD, LDV/SOF and Peg-IFN. Data on virologic response, adverse events, and biochemical and hematological parameters during and after therapy were analyzed. Also, concomitant drug use and drug-drug interactions were evaluated in patients receiving DAA regimen. Results: The median age was 48 (21-74) years, 5 (50%) of patients were female. 2 patients (20%) received LDV/SOF, 5 (50%) PROD and 3 (30%) Peg-IFN. Six of patients (60%) were HCV treatment-experienced and were failed to previous Peg-IFN therapy. All patients achieved sustained virologic response (100%). At the end of the one-year follow-up period, none of patients presented with HCV reactivation, and thus HCV was eliminated from our hemodialysis unit. No patient experienced serious adverse event leading to medication discontinuation during the course of treatment. Drug-drug interactions had to be modified with the treatment initiation in 2 out of 7 patients who received DAA. Conclusion: When multidrug use and comorbidities in hemodialysis patients are considered, multidisciplinary approach led by nephrologist are very important for increased access to treatment and more effective management of patients.
Authors and Affiliations
Şiyar Erdoğmuş
Keywords
Related Articles
- EP ID EP670503
- DOI 10.4274/atfm.galenos.2019.63522
- Views 114
- Downloads 0
Can Mean Platelet Volume be Used as a Marker in Children with Acute Appendicitis?
Introduction: The primary aim of this study was to investigate the diagnostic value of mean platelet volume (MPV) in the diagnosis of acute appendicitis and the effect of the presence of complication on MPV values in chi...
Chronic Hepatitis C Virus Infection in Hemodialysis Patients: Treatment Outcomes and Drug-drug Interactions Management
Objectives: The aim of this study was to evaluate the success of the paritaprevir/ritonavir/ombitasvir/dasabuvir (PROD), ledipasvir/sofosbuvir (LDV/ SOF) and peginterferon (Peg-IFN) alfa-2a in the elimination of chronic...
Primary Cardiac Tumors and Long-Term Results of Surgery: A 38-Year Experience in 81 Patients
Objectives: In this study, we examined our 38 years of institutional experience with 81 patients operated for primary cardiac tumor. Materials and Methods: Among the 81 patients included, 95% (n=77) had benign tumors and...
Knowledge and Attitudes of Parents Regarding Fever in Children
Introduction: Although fever is mostly not a sign of a serious disease, it causes concern in parents as well as frequent admissions to pediatric emergency units. Healthcare professionals are aware that fever is a natural...
The Cortico-hippocampal Circuit: The Brain’s Center for Mapping and Declarative Memory
Perceived stimuli from the external world are relayed to various association cortices after they reach their respective primary cortices. Information to be encoded as long-term memory is relayed to the dentate gyrus via...